The Testosterone Data I Could Not Fit Into One Free Article
A deeper scientific analysis of what our survey revealed about levels, satisfaction, dosing, and the clinical gaps women are still navigating
A deeper scientific analysis of what our survey revealed about levels, satisfaction, dosing, and the clinical gaps women are still navigating
In the free article I published, I focused on one central idea: many women may be told testosterone “doesn’t work” before they have ever reached a level that could reasonably be expected to help.
But the deeper I sit with this dataset, the more I realize that the story is bigger than undertreatment alone.
This is not simply a story about low testosterone. It is a story about a hormone therapy being used in real-world clinical practice without enough standardization, without enough patient access to laboratory data, without a female-specific FDA-approved product in the United States, and without enough clarity around what “response” actually means.
As a clinician, I find the data clinically useful. As a researcher, I find it hypothesis-generating. And as someone who listens to women every single day, I find it validating.
Because women are not just asking, “Can I take testosterone?”
They are asking a much more sophisticated question.
They are asking, “How do I know if this treatment is actually being optimized for me?”
